Marc Rubin

Directeur/Membre du Conseil chez CURIS, INC. Fortune : 50 161 $ au 31/05/2026

Profil

Marc Rubin currently works at Curis, Inc., as Independent Director from 2010, Soricimed Biopharma, Inc., as Director from 2018, and The Rogosin Institute, Inc., as Director.
Dr. Rubin also formerly worked at Titan Pharmaceuticals, Inc., as President & Chief Executive Officer from 2007 to 2009, Schering Berlin, Inc., as Chairman, Medarex, Inc., as Director from 2007 to 2009, Titan Pharmaceuticals, Inc., as Director from 2022 to 2023, Galectin Therapeutics, Inc., as Independent Director from 2018 to 2026, Surface Logix LLC, as Director from 2005 to 2011, Xequel Bio, Inc., as Director, Gemmus Pharma, Inc., as Independent Director from 2012 to 2014, Bayer Schering Pharma AG, as Head-Global Research & Development from 2006 to 2007, GSK Plc, as Senior Vice President-Global Clinical Pharmacology from 1990 to 2003, North Shore Medical Center, Inc., as Trustee, Bayer Pharma AG, as Head-Global Research & Development in 2007, Berlex Pharmaceuticals, Inc., as President, and Bayer HealthCare, as Member-Executive Committee.
Dr. Rubin received his doctorate degree in 1980 from Weill Cornell Medical College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GALECTIN THERAPEUTICS INC. 0,02 %	22/09/2025	13 581 ( 0,02 % )	34 224 $	31/05/2026
CURIS, INC. 0,07 %	23/03/2026	28 108 ( 0,07 % )	15 937 $	31/05/2026

Postes actifs de Marc Rubin

Sociétés	Poste	Début
CURIS, INC.	Directeur/Membre du Conseil	03/06/2010
The Rogosin Institute, Inc.	Directeur/Membre du Conseil	-
Soricimed Biopharma, Inc.	Directeur/Membre du Conseil	19/03/2018

Anciens postes connus de Marc Rubin

Sociétés	Poste	Fin
GALECTIN THERAPEUTICS INC.	Président	04/06/2018
TITAN PHARMACEUTICALS	Président	15/08/2022
Surface Logix LLC	Directeur/Membre du Conseil	01/01/2011
Medarex, Inc.	Directeur/Membre du Conseil	27/08/2009
TITAN PHARMACEUTICALS	Directeur Général	01/01/2009